Preview Mode Links will not work in preview mode

May 28, 2024

Featuring an interview with Dr Elias Jabbour, including the following topics:

  • Evolution of research and therapeutic options for acute lymphoblastic leukemia (ALL) (0:00)
  • Clinical and biological characteristics of ALL and implications for prognosis and disease management (6:36)
  • Case: A 48-year-old woman with newly diagnosed Philadelphia chromosome-positive (Ph-positive) ALL attains complete remission with ponatinib/blinatumomab (14:03)
  • Tolerability and improved quality of life with the chemotherapy-free combination of ponatinib and blinatumomab (24:17)
  • Case: A 38-year-old man with newly diagnosed Ph-positive ALL experiences a complete molecular response with induction hyper-CVAD and ponatinib (27:10)

CME information and select publications